Closing the Treatment Gap: How Patient Activation Strengthens Asthma Care

Building on Strong Beginnings  

Asthma patients often start their treatments with strong motivation. Inhalers are used regularly, symptoms improve, and adherence rates are high. Yet over time, persistence can waver. Routine sets in, symptoms may feel less urgent, and doses are quietly missed.  

This is the treatment gap: when patients begin with commitment but struggle to maintain it over the long term. Closing this gap is essential to ensuring that therapies deliver their full benefit.

Encouraging Trends in Adherence

The good news is that adherence in asthma care is achievable. According to the MyTherapy data:

• Over 77,000 asthma patients have engaged with MyTherapy in the past two years.

• At treatment start, adherence rates are especially strong — 85–90% across medication classes.

• Controller therapies, particularly combination treatments, sustain higher persistence, showing the value of long-term management.  

These findings highlight a clear opportunity: patients are motivated to succeed. With the right support, that early commitment can be transformed into lasting outcomes.

Turning Motivation into Persistence

High adherence at treatment start shows that patients want to manage their asthma effectively. To sustain that momentum, patient activation is key.

Activation means ensuring patients understand their therapies, recognize their benefits, and feel supported in managing daily routines. With activation, patients are more likely to:
• Stay committed to therapies over the long term
• Talk with their doctors about treatment options
• Take an active role in optimizing their care

Digital Support That Scales

With MyTherapy, pharma can run compliant patient activation campaigns that:
• Deliver educational content at the right moments
• Reinforce the importance of controller therapies
• Track behavior-based outcomes such as reminders and persistence  

This makes it possible to scale programs across markets while ensuring compliance and measurable impact.

Toward Better Outcomes in Asthma Care

Asthma treatment is not just about prescribing the right therapy. It’s about helping patients stay the course — day after day, month after month.  

The data shows that patients start strong. With patient activation and digital support, pharma can help ensure that strong beginnings lead to lasting success.

Because in asthma care, persistence is the difference between temporary relief and long-term control.